Magellan Diagnostics Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Magellan Diagnostics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8010988
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月21日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Magellan Diagnostics Inc (Magellan Diagnostics), formerly ESA Inc, a subsidiary of Meridian Bioscience Inc, is a medical device company that provides point-of-care systems, clinical laboratory instruments, and analytical laboratory services. The company’s products include LeadCare II, LeadCare ultra, and LEadCare plus systems. It offers analytical services such as lead and heavy metal exposure, monitoring exposure, and testing services. Magellan Diagnostics also provides education services for clinicians, policy makers, payers, families and communities about permanent health damages caused by lead. The company offers analytical services such as lead and heavy metal exposure, and monitoring exposure. Magellan Diagnostics is headquartered in North Billerica, Massachusetts, the US.

Magellan Diagnostics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Magellan Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Magellan Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Magellan Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Magellan Diagnostics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Magellan Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Magellan Diagnostics Inc, Medical Equipment, Deal Details 10
Private Equity 10
Telegraph Hill Partners Acquires Dynex Technologies 10
Partnerships 11
Magellan Diagnostics Enters into Distribution Agreement with Biofirm Technologies 11
Magellan Diagnostics Enters into Distribution Agreement with MedCaptain Medical Technology 12
Biohit Enters Into Distribution Agreement With Dynex Technologies 13
Magellan Biosciences Enters Into An Agreement With Bruker 14
Magellan BioScience Enters Into An Agreement With miacom diagnostics 15
Acquisition 16
Meridian Bioscience Acquires Magellan Diagnostics for USD66 Million 16
Thermo Fisher Scientific Acquires TREK Diagnostic Systems 18
Magellan Diagnostics Inc – Key Competitors 19
Magellan Diagnostics Inc – Key Employees 20
Magellan Diagnostics Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Legal and Regulatory 22
Oct 23, 2017: FDA warns Magellan Diagnostics of significant violations of the law as part of investigation into lead testing issues 22
Oct 23, 2017: Meridian Bioscience Comments on FDA Press Statement Regarding Its Warning Letter Issued to Magellan Diagnostics 23
Government and Public Interest 24
Jun 06, 2017: Meridian Bioscience Comments on Recent FDA Posting Related to Magellan Diagnostics 24
May 17, 2017: FDA warns Americans about risk of inaccurate results from certain lead tests 25
Product News 26
Jan 22, 2016: Instruments to Help Flint Physicians Quickly Test Patients’ Lead Exposure 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Magellan Diagnostics Inc, Medical Equipment, Key Facts 2
Magellan Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Magellan Diagnostics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Magellan Diagnostics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Magellan Diagnostics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Magellan Diagnostics Inc, Deals By Market, 2011 to YTD 2017 8
Magellan Diagnostics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Telegraph Hill Partners Acquires Dynex Technologies 10
Magellan Diagnostics Enters into Distribution Agreement with Biofirm Technologies 11
Magellan Diagnostics Enters into Distribution Agreement with MedCaptain Medical Technology 12
Biohit Enters Into Distribution Agreement With Dynex Technologies 13
Magellan Biosciences Enters Into An Agreement With Bruker 14
Magellan BioScience Enters Into An Agreement With miacom diagnostics 15
Meridian Bioscience Acquires Magellan Diagnostics for USD66 Million 16
Thermo Fisher Scientific Acquires TREK Diagnostic Systems 18
Magellan Diagnostics Inc, Key Competitors 19
Magellan Diagnostics Inc, Key Employees 20
Magellan Diagnostics Inc, Subsidiaries 21

★海外企業調査レポート[Magellan Diagnostics Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Chuang’s Consortium International Ltd:企業の戦略・SWOT・財務情報
    Chuang's Consortium International Ltd - Strategy, SWOT and Corporate Finance Report Summary Chuang's Consortium International Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Avista Corporation (AVA)-エネルギー分野:企業M&A・提携分析
    Summary Avista Corporation (Avista) is an electric and natural gas utility. The company produces, transmits, and distributes electricity; and supplies natural gas on retail and wholesale basis. It sources electricity from its facilities and contracted hydroelectric, thermal and wind generation facil …
  • Intellipharmaceutics International Inc (IPCI):製薬・医療:M&Aディール及び事業提携情報
    Summary Intellipharmaceutics International Inc (Intellipharmaceutics) is a pharmaceutical company that researches, develops, manufactures, and commercializes novel and generic targeted oral solid dosage pharmaceuticals. The company develops its controlled-release and targeted-release oral solid dosa …
  • Studsvik AB (SVIK):電力:M&Aディール及び事業提携情報
    Summary Studsvik AB (Studsvik) is a nuclear services company. It develops and delivers technical solutions to improve reactor performance, and reduce risks and costs across the nuclear and radioactive material lifecycle. The company offers fuel and reactor management software; advanced engineering a …
  • Sharjah Electricity & Water Authority:企業の戦略的SWOT分析
    Sharjah Electricity & Water Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Corning Incorporated:企業の戦略・SWOT・財務情報
    Corning Incorporated - Strategy, SWOT and Corporate Finance Report Summary Corning Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Endologix Inc (ELGX):企業の財務・戦略的SWOT分析
    Endologix Inc (ELGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Outset Medical, Inc.:医療機器:M&Aディール及び事業提携情報
    Summary Outset Medical, Inc., (Outset Medical) is a medical technology company engaged in developing hemodialysis system for the treatment of kidney diseases. The company offers Tablo Hemodialysis machine that makes water clean, produces dialysate, takes blood pressure, and delivers medication for p …
  • Intrexon Corp (XON):企業の財務・戦略的SWOT分析
    Summary Intrexon Corp (Intrexon), formerly Genomatix Corp is a synthetic biology service provider. The company operates through its divisions and units such as cell engineering, data sciences and computational biology, information technology (IT), actobiotics, molecular engineering, agricultural bio …
  • Science Applications International Corp
    Science Applications International Corp - Strategy, SWOT and Corporate Finance Report Summary Science Applications International Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Tofas Turk Otomobil Fabrikasi A.S.:企業の戦略・SWOT・財務情報
    Tofas Turk Otomobil Fabrikasi A.S. - Strategy, SWOT and Corporate Finance Report Summary Tofas Turk Otomobil Fabrikasi A.S. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Discovery Communications, Inc.
    Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report Summary Discovery Communications, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Wentworth Resources Ltd (WRL):企業の財務・戦略的SWOT分析
    Wentworth Resources Ltd (WRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Kforce Inc (KFRC):企業の財務・戦略的SWOT分析
    Kforce Inc (KFRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • CLP Holdings Limited:企業の戦略・SWOT・財務分析
    CLP Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary CLP Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Rigel Pharmaceuticals Inc (RIGL):製薬・医療:M&Aディール及び事業提携情報
    Summary Rigel Pharmaceuticals Inc. (Rigel) is a biotechnology company that discovers and develops innovative small-molecule drugs for patients with immune disorders, hematological disorders, cancer and rare diseases. Its research activities focus on signaling pathways that are critical to disease me …
  • DexTech Medical AB:製薬・医療:M&Aディール及び事業提携情報
    Summary DexTech Medical AB (DexTech) is a research company that conducts research in the areas of urological oncology, mainly within prostate cancer. The company develops product candidates based on a modified carbon hydrate molecule combined with active substances such as generics. Its technology p …
  • Mitsubishi Corporation:企業のM&A・事業提携・投資動向
    Mitsubishi Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mitsubishi Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Selecta Biosciences Inc (SELB):製薬・医療:M&Aディール及び事業提携情報
    Summary Selecta Biosciences Inc (Selecta Biosciences) is a biopharmaceutical company that develops immunotherapies and vaccines for the treatment and prevention of human diseases. The company’s pipeline products include SEL-212, SEL-403, SEL-302 and SEL-302. It utilizes synthetic vaccine particle (S …
  • Ezion Holdings Limited:企業のM&A・事業提携・投資動向
    Ezion Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ezion Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆